ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

330
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
24 Jul 2021 08:22

Asia Shorts: Tencent, CMB, Ping An, Weimob, WuXi, Shimano, Cocokara, HMM, Kakao, Doosan, Yang Ming

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
254 Views
Share
bullishWuxi Biologics
20 Jul 2021 18:54

Wuxi Biologics Placement - Similar Deal Will Yield Similar Results

Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...

Logo
359 Views
Share
bearishSamsung C&T
11 Jul 2021 16:20

KODEX Samsung Group ETF & Samsung C&T Stub's Harsh Discount

If we look at the trend of the price ratio of C&T versus Synthetic over the past two months, we can find something quite interesting in connection...

Logo
232 Views
Share
21 Jun 2021 09:53Syndicated

Samsung Is In A Crucial Transition

Samsung is a unique company: one of the best brand names to ever come out of East Asia, covering Samsung's history, where it is today and its future

Logo
215 Views
Share
bearishKakao Games
18 Jun 2021 11:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
487 Views
Share
x